Personalized antibiotics for lung infections in the ICU
Part of Infections, Lungs & breathing clinical trials.
This study tests whether quickly identifying the exact bacteria causing your lung infection and using special computer models to choose the best antibiotic dose can improve your recovery in the ICU. It aims to make antibiotic treatment more personalized and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older
- You must be in the intensive care unit (ICU)
- You must have a confirmed or suspected lung infection (pneumonia) with a severity score greater than 2
- You must give permission (consent) to participate, or your family can give it if you are too ill to decide
- You cannot have COVID-19, a severe allergy to penicillin-type drugs, or be pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving antibiotics in a personalized way, based on how your body processes them, works better than the standard dose for treating lung infections in the ICU. If you qualify, you'll be randomly assigned to get either the usual dose or a dose adjusted to your blood levels, with the goal of improving your recovery.
This trial tests a new way to quickly measure antibiotic levels in the blood of ICU patients, so doctors can adjust the dose for each person. It aims to make antibiotic therapy more effective and safer.
This trial tests a computer tool to help doctors choose the right antibiotic for sepsis early on. It may help improve treatment by providing personalized recommendations based on your condition.
This study tests whether giving inhaled antibiotics based on a patient's own airway bacteria can prevent ventilator-associated pneumonia (a lung infection from the breathing tube) in intensive care patients. It may help reduce infections in people who need a breathing tube for more than three days.
This trial tests whether a quick genetic test can help doctors choose the right treatment for patients with a suspected severe infection (sepsis) more quickly. The goal is to improve recovery by personalizing care based on your body's response.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
Hear when a new Pulmonary Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.